AbbVie signs $21 billion deal to acquire Pharmacyclics

AbbVie signs $21 billion deal to acquire Pharmacyclics

Pharmaceutical major AbbVie has announced $21 billion deal to acquire cancer drug maker Pharmacyclics Incorporated.

AbbVie Buys Shire for $55 Billion

AbbVie Buys Shire for $55 Billion

AbbVie bio-pharmaceutical company had signed a deal of $55 billion with Shire PLC on Friday. The deal between two reputed companies is considered as largest deal for the year.

To cut down the tax bill, the North Chicago-based AbbVie company decided to join hands with Shire. The tax rate of the company will be reduced to 13 % from 22 % in 2016.

In a Friday morning conference call with analysts, AbbVie Chief Executive Officer Richard Gonzalez said, "AbbVie's rationale for the deal goes well beyond the tax impact. He added that Shire's portfolio of drugs is an "excellent strategic fit".

Interesting Stories

Coca-Cola Co.’s Three Bottlers in Europe in Talks for Merger

Coca-Cola Enterprises, the anchor bottler for Western Europe, is in discussions with its Iberian and German counterparts about a merger. The bottler is planning a three-way deal that would simplify the manufacturing of products for the world’s...

Science Stories

Nearest Rocky Exoplanet to Our Solar System Discovered

Using Galileo National Telescope in the Canary Islands, scientists have found nearest rocky exoplanet outside our solar system. The exoplanet is just 21 light years away from earth and orbits another star.

Though it is quite near to earth...